Cionic’s Neural Sleeve Granted FDA Clearance

Neural Sleeve™ First Algorithm-Powered Bionic Garment Designed to Help Those with Mobility Issues due to Multiple Sclerosis, Stroke, Cerebral Palsy, and Other Conditions, Regain Functional Movement in Everyday Activities - In-Market Later This Year

Cionic, a company committed to improving the lives of people with mobility differences by helping them move more independently through bionic clothing, is proud to announce that its first product offering, the lightweight leg-worn Cionic Neural Sleeve™, has been granted FDA clearance for “functional electrical stimulation to assist in gait for people with foot drop and leg muscle weakness.”

This FDA clearance allows Cionic to take their Neural Sleeve to market and begin actively helping people with mobility issues due to Multiple Sclerosis (MS), stroke, Cerebral Palsy (CP), and other neurological conditions. Ushering in a new age of wearable technology, the Cionic Neural Sleeve is the first product to combine movement analysis and augmentation into a wearable garment.

“We are incredibly excited for the Cionic Neural Sleeve to be an FDA cleared Class II medical device and are ready to start impacting the lives of individuals with movement challenges in meaningful ways,” said Jeremiah Robison, Founder and CEO of Cionic. “Our mission is to become the new standard of care by addressing the underlying brain body connections, enabling confident movement, and greater engagement in the community.”

The lightweight and durable Neural Sleeve is designed to help people walk, a fundamental activity key to independent living, however, Cionic has built their platform from the ground up to enable solutions across the mobility spectrum. Cionic completed human factors and efficacy testing and submitted the Neural Sleeve for FDA clearance in November 2021.

“This would not have been possible without the more than 70 individuals across multiple sclerosis, stroke, cerebral palsy, and spinal cord injury who participated in our trials.  Together with our research partners at Cleveland State University we were able to demonstrate statistically significant improvement to foot clearance, leading to more stable and confident walking,” continued Robison.

Jim Vecchi, who has been participating in Cionic’s MS trials, describes his experience with the Neural Sleeve.

“Wearing the Neural Sleeve, I move in a way that is more flowing and natural. I am walking more quickly and smoothly, while using less energy in doing so. Already I feel that I am getting stronger and more endurant,” said Jim Vecchi, trial patient. “I should also mention that the Neural Sleeve is surprisingly comfortable and my body has become accustomed to wearing it surprisingly quickly. I do not have the words to properly explain the positive effects on my confidence and outlook. I very much look forward to seeing what progress I can make with the help of the Neural Sleeve.”

Individuals interested in pre-ordering the Neural Sleeve may join our Founder’s Program starting now at for delivery later this year.

Cionic was founded in 2018 by tech innovator Jeremiah Robison, who was motivated by his daughter’s mobility journey after her Cerebral Palsy diagnosis. The company is on a mission to help all individuals with neurological disorders and injuries move without limits. For general mobility impairment, the current standard of care is quite basic – orthoses, walkers, wheelchairs – durable medical equipment that has been around for almost a century. Other treatments include pharmaceuticals, surgical procedures, and physical therapy.

The Cionic Neural Sleeve analyzes, predicts, and augments a person’s movement. Using advanced algorithms, the system reads the signal sent from the brain to the muscles and can predict a person’s movement 1/10th of a second before their foot lifts off the ground. The Neural Sleeve uses a dense array of sensors to measure how the body is positioned and how individual muscles fire during movement, predicts intended movement by measuring the electrical signal from the brain, and then algorithms analyze this data in real time to determine optimal muscle activation patterns. Cionic delivers Functional Electrical Stimulation to sequence proper muscle firing for natural movement. It is an adaptive system that provides real-time augmentation and adjustment of the participant’s movement, providing necessary assistance based on what can be measured of the participant’s neurological feedback that adjusts stimulation based on measured gait kinematics to optimize performance.

The company’s discreet bionic clothing is designed and engineered to assist people with mobility challenges. Constructed with soft, flexible fabric fitted to an individual’s leg, the Neural Sleeve will be available in a variety of colors to match your personal style. The company is the first to combine movement analysis and augmentation into a wearable — the Sleeve’s sleek, mobile design makes it easy to integrate into everyday life, helping people move more independently.

Medical Device News Magazine
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy